Kezar Life Sciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Kezar Life Sciences Inc: Is Infosys Ltd. worth buying?
Item: Kezar Life Sciences Inc
Rating: 1.50600
Author: Trendlyne DVM scores

about

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetom...

7.29 -0.07 (-0.95%)

Near 52W High of $7.55

616.0K

XNAS Volume

High volume today

XNAS 08 May, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.0 / 100

Technically Moderately Bullish

60.2 / 100

1Yr Price target upside is 1%

3 analysts

Kezar Life Sciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kezar Life Sciences Inc Live Stock Price Today, Share Analysis and Chart

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetom...

Near 52W High of $7.55

High volume today

SWOT Analysis

Kezar Life Sciences Inc Live Price Chart